{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:50:35Z","timestamp":1783025435927,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.metabol.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T12:02:38Z","timestamp":1400155358000},"page":"989-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Testosterone therapy, thrombosis, thrombophilia, cardiovascular events"],"prefix":"10.1016","volume":"63","author":[{"given":"Charles J.","family":"Glueck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamainternmed.2013.6895","article-title":"Trends in androgen prescribing in the United States, 2001 to 2011","volume":"173","author":"Baillargeon","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0010","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.05.005_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MED.0b013e32835ed58b","article-title":"An update on menopausal hormone replacement therapy in women and cardiovascular disease","volume":"20","author":"Valdiviezo","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.metabol.2014.05.005_bb0025","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1210\/jc.2010-0858","article-title":"Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal","volume":"95","author":"Anawalt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5694\/mja11.11299","article-title":"Disease mongering and low testosterone in men: the tale of two regulatory failures","volume":"196","author":"Vitry","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.metabol.2014.05.005_bb0035","first-page":"836","article-title":"Testosterone Lab Testing and Initiation in the United Kingdom and the United States, 2000\u20132011","volume":"993","author":"Layton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0040","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0050","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2605.2006.00720.x","article-title":"Endogenous testosterone levels and smoking in men. The fifth Tromso study","volume":"30","author":"Svartberg","year":"2007","journal-title":"Int J Androl"},{"key":"10.1016\/j.metabol.2014.05.005_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.14310\/horm.2002.1445","article-title":"Cigarette smoking has a positive and independent effect on testosterone levels","volume":"12","author":"Wang","year":"2013","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.metabol.2014.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1743-6109.2006.00334.x","article-title":"Wide variability in laboratory reference values for serum testosterone","volume":"3","author":"Lazarou","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0070","first-page":"923","article-title":"Reliability and validity of serum sex hormone measurements","volume":"5","author":"McShane","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2014.05.005_bb0075","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1373\/clinchem.2012.186569","article-title":"Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the Partnership for the Accurate Testing of Hormones","volume":"58","author":"Yun","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.05.005_bb0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"New End J Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1076029613499819","article-title":"Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study","volume":"20","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2217\/WHE.13.31","article-title":"Thrombosis in three postmenopausal women receiving testosterone therapy for low libido","volume":"9","author":"Glueck","year":"2013","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.metabol.2014.05.005_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trsl.2011.06.003","article-title":"Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia","volume":"158","author":"Glueck","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.metabol.2014.05.005_bb0100","article-title":"Testosterone, thrombophilia, thrombosis","author":"Glueck Charles","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.metabol.2014.05.005_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1076029613485154","article-title":"Testosterone, thrombophilia, and thrombosis","volume":"20","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MBC.0000000000000047","article-title":"Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws","volume":"25","author":"Pandit","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.metabol.2014.05.005_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.05.005_bb0125","doi-asserted-by":"crossref","first-page":"e8595","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle WD","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.05.005_bb0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s11999-008-0148-0","article-title":"Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head","volume":"466","author":"Glueck","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.metabol.2014.05.005_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/1076029612449901","article-title":"The role of the factor V leiden mutation in osteonecrosis of the hip","volume":"19","author":"Glueck","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjmed.2012.07.025","article-title":"Hospital costs of acute pulmonary embolism","volume":"126","author":"Fanikos","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0145","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0150","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1177\/1076029610387587","article-title":"The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study","volume":"17","author":"Douketis","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.metabol.2014.05.005_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erc.09.175","article-title":"Venous thromboembolism in women taking hormonal contraceptives","volume":"8","author":"Blanco-Molina","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.metabol.2014.05.005_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrendo.2013.73","article-title":"Risks and benefits of testosterone therapy in older men","volume":"9","author":"Spitzer","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0180","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1055\/s-0032-1325616","article-title":"Iatrogenic hyperviscosity and thrombosis","volume":"38","author":"Baskurt","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1309\/B29E2AHMTQA1KAKJ","article-title":"Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis","volume":"127","author":"Peerschke","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0195","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.05.005_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pathophys.2008.04.007","article-title":"Obesity and vascular dysfunction","volume":"15","author":"Stapleton","year":"2008","journal-title":"Pathophysiology"},{"key":"10.1016\/j.metabol.2014.05.005_bb0205","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/en.2003-0789","article-title":"Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway","volume":"145","author":"Death","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.05.005_bb0210","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/07853890.2010.497767","article-title":"The role of monocytes in atherosclerotic coronary artery disease","volume":"42","author":"Pamukcu","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-0760(03)00105-5","article-title":"Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers","volume":"84","author":"Urhausen","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0220","first-page":"4500","article-title":"Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men","volume":"85","author":"Swerdloff","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.005_bb0225","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism \u2013 results from a randomized, double-blind, clinical trial","volume":"85","author":"Hoibraaten","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0230","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.05.005_bb0235","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0240","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since, menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.05.005_bb0245","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.1973.03230060030009","article-title":"Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research, Group","volume":"226","author":"The Coronary Drug Project","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.05.005_bb0250","first-page":"165","article-title":"Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies","author":"Byar","year":"1988","journal-title":"NCI Monogr"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2014.05.005_bb0255","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0049-3848(09)70015-5","article-title":"Mechanisms of thrombosis related to hormone therapy","volume":"123","author":"Sandset","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.metabol.2014.05.005_bb0260","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1212\/01.WNL.0000149639.25136.CA","article-title":"The role of aromatization in testosterone supplementation: effects on cognition in older men","volume":"64","author":"Cherrier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2014.05.005_bb0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-006-9212-1","article-title":"Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: case report and review of the literature","volume":"99","author":"Lycette","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.metabol.2014.05.005_bb0270","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-08-0888","article-title":"Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study","volume":"160","author":"Svartberg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jth.12484","article-title":"Endogenous sex hormones and risk of venous thromboembolism in women and men","volume":"12","author":"Holmegard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2014.05.005_bb0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001721-200301000-00017","article-title":"Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations","volume":"14","author":"Lapecorella","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.metabol.2014.05.005_bb0285","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0026-0495(97)90232-8","article-title":"Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men","volume":"46","author":"De Pergola","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.05.005_bb0290","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MBC.0b013e32833894eb","article-title":"Recurrent deep vein thrombosis and pulmonary embolism in a young man with Klinefelter's syndrome and heterozygous mutation of MTHFR-677C>T and 1298A>C","volume":"21","author":"Angel","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.metabol.2014.05.005_bb0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1468-3083.2004.01117.x","article-title":"Increased activity of factor VIII coagulant associated with venous ulcer in a patient with Klinefelter's syndrome","volume":"19","author":"Dissemond","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/RHU.0b013e31817de084","article-title":"Antiphospholipid syndrome in a 21-year-old with Klinefelter syndrome","volume":"15","author":"Mount","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.metabol.2014.05.005_bb0305","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/pgmj.73.865.761","article-title":"Thrombophilia in a man with long-standing hypogonadism","volume":"73","author":"Ranganath","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.metabol.2014.05.005_bb0310","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2169\/internalmedicine.48.1985","article-title":"Serious venous thromboembolism, heterozygous factor V Leiden and prothrombin G20210A mutations in a patient with Klinefelter syndrome and type 2 diabetes","volume":"48","author":"Ayli","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.metabol.2014.05.005_bb0315","doi-asserted-by":"crossref","first-page":"108:1","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:04:39Z","timestamp":1758427479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0026049514001450"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.05.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone therapy, thrombosis, thrombophilia, cardiovascular events","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}